SlideShare a Scribd company logo
Validity and Reliability
of
Analytical Tests
BY
DR MUHAMMAD TAUSEEF JAVED
CONSULTANT MINISTRY OF HEALTH
MAKKAH
&
IPH LAHORE
Analytical Tests include both:
• Screening Tests
• Diagnostic Tests
•Two Important Objectives
To distinguish between people in the
population who have the diseases and
those who do not
To determine how good the test is in
separating populations of people with
and without the disease in question?
Epidemiological
Surveillance
vs.
Screening
Epidemiological
Surveillance
• What is it?
• Why do it?
Epidemiological
Surveillance
• Definition - ongoing & systematic
collection, analysis & interpretation of data
related to health, disease & conditions
• Two types
Passive Surveillance – uses available data or
reporting from health care provider or
regional health officer
Active Surveillance – periodic field visits to
health care facilities to identify new cases
• The present approach is the survey
Epidemiological
Surveillance
• Why do it?
Can help discover and control the
transmission of infectious diseases
Prevention and control programs can be
planned and implemented
Screening
• Definition - use of quick and simple
testing procedures to identify and
separate persons:
who have a disease from those that do not
OR
who are apparently (appear to be) well, but
who may be at risk of a disease, from
those who probably don’t have the
disease.
Terms Related to
Screening Tests
• Validity - relates to accuracy (correctness)
• Reliability - repeatability
• Yield - the # of tests that can be done in a
time period
Terms Related to Screening
Tests (cont’d)
• Sensitivity - ability of a test to
identify those who have disease
• Specificity - ability of a test to
exclude those who don’t have
disease
Terms Related to Screening
Tests (cont’d)
• Tests with dichotomous results – tests
that give either positive or negative
results
• Tests of continuous variables – tests that
do not yield obvious “positive” or
“negative” results, but require a cutoff
level to be established as criteria for
distinguishing between “positive” and
“negative” groups
An important public health
consideration, particularly in screening
free-living populations, is:
How good is the test at
identifying people
with the disease
and without the disease?
In other words:
If we screen a population, what
proportion of people who have the
disease will be correctly identified?
POPULATION
Test Results With Disease
Without
Disease
Positive
True Positive
(TP)
False Positive
(FP)
Negative
False Negative
(FN)
True Negative
(TN)
Sensitivity = = X 100
True positives
True positives +
false negatives
True positives
All persons with
the disease
= TP
TP + FN
Specificity = = X 100
True negatives
True negatives+
false positives
True negatives
All persons
without the
disease
= TN
TN + FP
Percent false negatives = % of people with the disease who
were not detected by the test
FN
FN + TP X 100
Percent false positives = % of people without the disease
who were incorrectly labeled by the
test as having the disease
FP
FP + TN X 100
In the clinical setting, a more important
question is:
If the test results are positive (or
negative) in a given patient, what is
the probability that this patient has (or
does not have) the disease?
In other words:
What proportion of patients who test
positive (or negative) actually have (or do
not have) the disease in question?
Predictive Value
Pos. PV = X 100 = %True Positives
TP + FP
Neg. PV = X 100 = %True Negatives
TN + FN
Biologic Variation of
Human Populations &
Diagnostic Issues
Distribution of Tuberculin Reactions
Bimodal Distribution
Easy to distinguish
between exposed group
and those not exposed.
Distribution of
Systolic Blood Pressure
Unimodal Distribution
With continuous variables, a
cutoff level must be established
to separate the hypertensive
group. Could choose based on
statistics, but better to base on
biologic considerations.
Effects of
Choosing
Different Cutoff
Levels for
Diabetes
Diagnosis in
Population with
50% Prevalence
Real World
Pseudo-
Real World
The major issue with deciding
to set a cutoff high or low
is the problem of
false positives
and false negatives.
Possible Groups
with Dichotomous Test
True Disease
Status is Known,
as with dichotomous tests.
Grouping All Positives
and All Negatives
True Disease Status
is Unknown,
as with continuous variables.
Artificial
Cutoff
•Use of Multiple Screening
Tests
Sequential (Two-stage) Testing
Simultaneous Testing
Hypothetical Two-Stage Screening
Only Pos. Test 1
are given Test 2
Hypothetical Two-Stage Screening (cont.)
TEST 2 (Glucose Tolerance Test)
Sensitivity = 90%
Specificity = 90%
DIABETES
+ -
TEST
RESULTS +
315 190 505
- 35 1710 1745
350 1900 2250
Net Sensitivity = 315/500 = 63%
Net Specificity = 7600 + 1710 = 98%
9500
Predictive Value
Prevalence & Predictive Value
Positive
As prevalence increases,
positive predictive value increases.
Prevalence & Predictive Value
Note: Test has
95% sensitivity and
95% specificity
Specificity &
Predictive
Value
As specificity
increases,
positive predictive
value increases.
As sensitivity increases,
positive predictive value
also increases, but to a
much lesser extent.
Specificity & Predictive Value
As specificity increases,
positive predictive value increases.
Results
reliable but
NOT valid
Results
reliable and
valid
Reliability (Repeatability) of Tests

More Related Content

PPTX
Screening test (basic concepts)
PPTX
Bias, Confounding, and Interaction.pptx
PPT
Validity of a screening test
PPTX
Case Control Study Design
PPT
Case Control Studies
PPTX
Confounding and interaction seminar
PDF
Bias and Confounding
PPTX
Sampling and sampling technique
Screening test (basic concepts)
Bias, Confounding, and Interaction.pptx
Validity of a screening test
Case Control Study Design
Case Control Studies
Confounding and interaction seminar
Bias and Confounding
Sampling and sampling technique

What's hot (20)

PPT
Measures Of Association
PPTX
Confounder and effect modification
PPTX
Validity & reliability of screening & diagnostic tests
PDF
Cross sectional study
PPT
Criteria for causal association
PDF
Study designs, Epidemiological study design, Types of studies
PPTX
Case control study
PPTX
cohort study
PPT
Screening tests
PPT
3 cross sectional study
PPT
Epidemiology Study Design
PPTX
DALYs and QALYs by samrat gurung
PPTX
Nested case control,
PPTX
Cross sectional study
PPSX
Bias, confounding and fallacies in epidemiology
PPTX
Randomized controlled trial: Going for the Gold
PPT
DESCRIPTIVE EPIDEMIOLOGY
PDF
Standardization of rates
PPTX
Odds ratios (Basic concepts)
PDF
Study designs
Measures Of Association
Confounder and effect modification
Validity & reliability of screening & diagnostic tests
Cross sectional study
Criteria for causal association
Study designs, Epidemiological study design, Types of studies
Case control study
cohort study
Screening tests
3 cross sectional study
Epidemiology Study Design
DALYs and QALYs by samrat gurung
Nested case control,
Cross sectional study
Bias, confounding and fallacies in epidemiology
Randomized controlled trial: Going for the Gold
DESCRIPTIVE EPIDEMIOLOGY
Standardization of rates
Odds ratios (Basic concepts)
Study designs
Ad

Viewers also liked (20)

PPT
Reliability and validity
PPT
Reliability and validity
PPT
Presentation Validity & Reliability
PPT
Reliability and validity
PPTX
Validity and Reliability
PPTX
Validity, reliability & practicality
PPTX
Validity and reliability of questionnaires
PPSX
Phase III Randomized Controlled Trial to Compare the Efficacy and safety of P...
PPTX
Validity Study Barbados NVQ-B
PPTX
Joint Architecture Bio mechanics (Presentation)
PDF
Aspects of Validity
PPTX
Long bone
PPT
History of Manual Therapy and Arthrology
PPTX
measurment, testing & eveluation
PPTX
Measurement and evaluation
PPT
Validity And Reliabilty
PPT
Reliability and validity1
PDF
Sensitivity specificity
PPT
Sampling methods
PPTX
Physio.co.uk : An introduction to mobilisation and manual therapy
Reliability and validity
Reliability and validity
Presentation Validity & Reliability
Reliability and validity
Validity and Reliability
Validity, reliability & practicality
Validity and reliability of questionnaires
Phase III Randomized Controlled Trial to Compare the Efficacy and safety of P...
Validity Study Barbados NVQ-B
Joint Architecture Bio mechanics (Presentation)
Aspects of Validity
Long bone
History of Manual Therapy and Arthrology
measurment, testing & eveluation
Measurement and evaluation
Validity And Reliabilty
Reliability and validity1
Sensitivity specificity
Sampling methods
Physio.co.uk : An introduction to mobilisation and manual therapy
Ad

Similar to Validity and Reliability (20)

PPT
Lecture 3 -Screening tests.ppt presentation
PPTX
Diagnostic test and agreement.pptx
PPTX
Testing and Screening Nov 2021-undergraduate.pptx
PDF
chapter2-191105204556.pdf
PPTX
evalution for screening test and its importance .pptx
PPTX
SCREENING-1.pptx including sensitivity .
PPTX
VALIDITY AND RELIABLITY OF A SCREENING TEST seminar 2.pptx
PPTX
Chapter 2.2 screening test
PPTX
Screening for diseases.pptx
PPT
05 diagnostic tests cwq
PDF
6 Screening in Public Health-converted.pdf
PPTX
Diagnotic and screening tests
PDF
Probability.pdf.pdf and Statistics for R
PPT
Diagnostic tests - research .-6thoct.ppt
PPTX
Chapter- 1 Introduction (1).pptx to hematolooogyy
PPTX
Diagnostic test
PPTX
screening of diseases IN PUBLIC HEALTH .pptx
PPT
Disease screening and screening test validity
PPTX
SCREENING.pptx
PPT
Dr swe swe latt screening for slideshare
Lecture 3 -Screening tests.ppt presentation
Diagnostic test and agreement.pptx
Testing and Screening Nov 2021-undergraduate.pptx
chapter2-191105204556.pdf
evalution for screening test and its importance .pptx
SCREENING-1.pptx including sensitivity .
VALIDITY AND RELIABLITY OF A SCREENING TEST seminar 2.pptx
Chapter 2.2 screening test
Screening for diseases.pptx
05 diagnostic tests cwq
6 Screening in Public Health-converted.pdf
Diagnotic and screening tests
Probability.pdf.pdf and Statistics for R
Diagnostic tests - research .-6thoct.ppt
Chapter- 1 Introduction (1).pptx to hematolooogyy
Diagnostic test
screening of diseases IN PUBLIC HEALTH .pptx
Disease screening and screening test validity
SCREENING.pptx
Dr swe swe latt screening for slideshare

More from Tauseef Jawaid (20)

PPTX
Normal distribution and Z score Test for post graduate and undergraduate stu...
PPTX
Lecture chi squire. For Postgraduate and Undergraduate
PPTX
LECTURE BEHAVIOUR CHANGE INTERVENTION GMC.pptx
PPTX
Vector Borne Diseases.pptx
PPT
Zoonotic Diseases
PPTX
Synopsis -Study proposal.pptx
PPT
LECT - HMIS= BY Prof Tauseef Jawaid.ppt
PPT
Lecture Sampling Methods by Prof: Dr Tauseef Jawaid.ppt
PPT
SCREENING LECTURE GMC 2023.ppt
PPT
Epidemiological study Design Case Control And Cohort Study.ppt
PPT
Basic statistical Measues.ppt
PPT
Introduction to Biostatistics.ppt
PPTX
Measures of Epidemiolgy GMC CLASS.pptx
PPT
Demography and Pyramids Of Pakistan
PPT
Epidemiological study designs
PPTX
Disease causation. lecture 2021 2022 class-1
PPSX
Lec levels of prevention intervention 2021-22
PPT
Lec levels of prevention intervention 2021
PPSX
Health and disease lecture 2021-Class
PPTX
Sexual Transmitted Diseases and STI infection
Normal distribution and Z score Test for post graduate and undergraduate stu...
Lecture chi squire. For Postgraduate and Undergraduate
LECTURE BEHAVIOUR CHANGE INTERVENTION GMC.pptx
Vector Borne Diseases.pptx
Zoonotic Diseases
Synopsis -Study proposal.pptx
LECT - HMIS= BY Prof Tauseef Jawaid.ppt
Lecture Sampling Methods by Prof: Dr Tauseef Jawaid.ppt
SCREENING LECTURE GMC 2023.ppt
Epidemiological study Design Case Control And Cohort Study.ppt
Basic statistical Measues.ppt
Introduction to Biostatistics.ppt
Measures of Epidemiolgy GMC CLASS.pptx
Demography and Pyramids Of Pakistan
Epidemiological study designs
Disease causation. lecture 2021 2022 class-1
Lec levels of prevention intervention 2021-22
Lec levels of prevention intervention 2021
Health and disease lecture 2021-Class
Sexual Transmitted Diseases and STI infection

Recently uploaded (20)

PDF
Dermatology diseases Index August 2025.pdf
PPTX
community services team project 2(4).pptx
PPTX
Genaralised anxiety disorder presentation
PPTX
Importance of Immediate Response (1).pptx
PPT
Microscope is an instrument that makes an enlarged image of a small object, t...
PPTX
ABG advance Arterial Blood Gases Analysis
PDF
MECE & SCQA FRAMEWORKS, - Adding Innovation & Influencing Hospital & Super-Sp...
PPTX
Galactosemia pathophysiology, clinical features, investigation and treatment ...
PDF
Priorities Critical Care Nursing 7th Edition by Urden Stacy Lough Test Bank.pdf
PPTX
AI_in_Pharmaceutical_Technology_Presentation.pptx
PDF
2E-Learning-Together...PICS-PCISF con.pdf
PPT
Adrenergic drugs (sympathomimetics ).ppt
PPTX
Basics of pharmacology (Pharmacology I).pptx
PDF
Megan Miller Colona Illinois - Passionate About CrossFit
PPTX
BLS, BCLS Module-A life saving procedure
PPTX
Bronchial_Asthma_in_acute_exacerbation_.pptx
PPTX
Current Treatment Of Heart Failure By Dr Masood Ahmed
PPTX
HEMODYNAMICS - I DERANGEMENTS OF BODY FLUIDS.pptx
PDF
CHAPTER 9 MEETING SAFETY NEEDS FOR OLDER ADULTS.pdf
PDF
A Brief Introduction About Malke Heiman
Dermatology diseases Index August 2025.pdf
community services team project 2(4).pptx
Genaralised anxiety disorder presentation
Importance of Immediate Response (1).pptx
Microscope is an instrument that makes an enlarged image of a small object, t...
ABG advance Arterial Blood Gases Analysis
MECE & SCQA FRAMEWORKS, - Adding Innovation & Influencing Hospital & Super-Sp...
Galactosemia pathophysiology, clinical features, investigation and treatment ...
Priorities Critical Care Nursing 7th Edition by Urden Stacy Lough Test Bank.pdf
AI_in_Pharmaceutical_Technology_Presentation.pptx
2E-Learning-Together...PICS-PCISF con.pdf
Adrenergic drugs (sympathomimetics ).ppt
Basics of pharmacology (Pharmacology I).pptx
Megan Miller Colona Illinois - Passionate About CrossFit
BLS, BCLS Module-A life saving procedure
Bronchial_Asthma_in_acute_exacerbation_.pptx
Current Treatment Of Heart Failure By Dr Masood Ahmed
HEMODYNAMICS - I DERANGEMENTS OF BODY FLUIDS.pptx
CHAPTER 9 MEETING SAFETY NEEDS FOR OLDER ADULTS.pdf
A Brief Introduction About Malke Heiman

Validity and Reliability

  • 1. Validity and Reliability of Analytical Tests BY DR MUHAMMAD TAUSEEF JAVED CONSULTANT MINISTRY OF HEALTH MAKKAH & IPH LAHORE
  • 2. Analytical Tests include both: • Screening Tests • Diagnostic Tests
  • 3. •Two Important Objectives To distinguish between people in the population who have the diseases and those who do not To determine how good the test is in separating populations of people with and without the disease in question?
  • 6. Epidemiological Surveillance • Definition - ongoing & systematic collection, analysis & interpretation of data related to health, disease & conditions • Two types Passive Surveillance – uses available data or reporting from health care provider or regional health officer Active Surveillance – periodic field visits to health care facilities to identify new cases • The present approach is the survey
  • 7. Epidemiological Surveillance • Why do it? Can help discover and control the transmission of infectious diseases Prevention and control programs can be planned and implemented
  • 8. Screening • Definition - use of quick and simple testing procedures to identify and separate persons: who have a disease from those that do not OR who are apparently (appear to be) well, but who may be at risk of a disease, from those who probably don’t have the disease.
  • 9. Terms Related to Screening Tests • Validity - relates to accuracy (correctness) • Reliability - repeatability • Yield - the # of tests that can be done in a time period
  • 10. Terms Related to Screening Tests (cont’d) • Sensitivity - ability of a test to identify those who have disease • Specificity - ability of a test to exclude those who don’t have disease
  • 11. Terms Related to Screening Tests (cont’d) • Tests with dichotomous results – tests that give either positive or negative results • Tests of continuous variables – tests that do not yield obvious “positive” or “negative” results, but require a cutoff level to be established as criteria for distinguishing between “positive” and “negative” groups
  • 12. An important public health consideration, particularly in screening free-living populations, is: How good is the test at identifying people with the disease and without the disease? In other words: If we screen a population, what proportion of people who have the disease will be correctly identified?
  • 13. POPULATION Test Results With Disease Without Disease Positive True Positive (TP) False Positive (FP) Negative False Negative (FN) True Negative (TN)
  • 14. Sensitivity = = X 100 True positives True positives + false negatives True positives All persons with the disease = TP TP + FN
  • 15. Specificity = = X 100 True negatives True negatives+ false positives True negatives All persons without the disease = TN TN + FP
  • 16. Percent false negatives = % of people with the disease who were not detected by the test FN FN + TP X 100
  • 17. Percent false positives = % of people without the disease who were incorrectly labeled by the test as having the disease FP FP + TN X 100
  • 18. In the clinical setting, a more important question is: If the test results are positive (or negative) in a given patient, what is the probability that this patient has (or does not have) the disease? In other words: What proportion of patients who test positive (or negative) actually have (or do not have) the disease in question?
  • 19. Predictive Value Pos. PV = X 100 = %True Positives TP + FP Neg. PV = X 100 = %True Negatives TN + FN
  • 20. Biologic Variation of Human Populations & Diagnostic Issues
  • 21. Distribution of Tuberculin Reactions Bimodal Distribution Easy to distinguish between exposed group and those not exposed.
  • 22. Distribution of Systolic Blood Pressure Unimodal Distribution With continuous variables, a cutoff level must be established to separate the hypertensive group. Could choose based on statistics, but better to base on biologic considerations.
  • 23. Effects of Choosing Different Cutoff Levels for Diabetes Diagnosis in Population with 50% Prevalence Real World Pseudo- Real World
  • 24. The major issue with deciding to set a cutoff high or low is the problem of false positives and false negatives.
  • 25. Possible Groups with Dichotomous Test True Disease Status is Known, as with dichotomous tests.
  • 26. Grouping All Positives and All Negatives True Disease Status is Unknown, as with continuous variables. Artificial Cutoff
  • 27. •Use of Multiple Screening Tests Sequential (Two-stage) Testing Simultaneous Testing
  • 28. Hypothetical Two-Stage Screening Only Pos. Test 1 are given Test 2
  • 29. Hypothetical Two-Stage Screening (cont.) TEST 2 (Glucose Tolerance Test) Sensitivity = 90% Specificity = 90% DIABETES + - TEST RESULTS + 315 190 505 - 35 1710 1745 350 1900 2250 Net Sensitivity = 315/500 = 63% Net Specificity = 7600 + 1710 = 98% 9500
  • 31. Prevalence & Predictive Value Positive As prevalence increases, positive predictive value increases.
  • 32. Prevalence & Predictive Value Note: Test has 95% sensitivity and 95% specificity
  • 33. Specificity & Predictive Value As specificity increases, positive predictive value increases. As sensitivity increases, positive predictive value also increases, but to a much lesser extent.
  • 34. Specificity & Predictive Value As specificity increases, positive predictive value increases.
  • 35. Results reliable but NOT valid Results reliable and valid Reliability (Repeatability) of Tests